Benoit Bouche, President and CEO, Nexelis, told Lu Rahman about the company's recent acquisition and what it means for the business and the vaccine sector. Nexelis is a leading provider of assay development and advanced laboratory testing services in the infectious diseases, metabolic diseases, and oncology fields. The company – which Benoit Bouche, President and […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!